Background. Despite complete surgical excision, malignant thymomas oft
en recur with resultant death. We reviewed our series to determine whi
ch factors independently predict survival after surgical resection. Me
thods. A retrospective analysis of patients operated on for thymoma be
tween 1949 and 1993 at Memorial Sloan-Kettering Cancer Center was perf
ormed. Clinical data were collected from chart review. Only patients w
ith a pathology report confirming the diagnosis of thymoma were includ
ed in this analysis. Kaplan-Meier survival curves were generated and c
omparisons of survival analyzed by log rank test. Multivariate analysi
s was performed by the Cox proportional hazards model. Results. One hu
ndred eighteen patients with thymoma underwent operation. There were 8
6 complete resections (73%), 18 partial resections (15%), and 14 biops
ies (12%). By Masaoka staging, 25 patients were stage I (21%), 41 stag
e II (35%), 43 stage III (36%), and 9 stage IVa (8%). Overall survival
was 77% at 5 years and 55% at 10 years. Tumor recurred in 25 (29%) of
86 completely resected thymomas. Stage of disease (p = 0.03) was the
only independent prognostic factor affecting recurrence. By multivaria
te analysis, stage (p = 0.003), tumor size (p = 0.0001), histology (p
= 0.004), and extent of surgical resection (p = 0.0006) were independe
nt predictors of long-term survival. Conclusions. Patients with stage
I disease require no further therapy after complete surgical resection
. Neoadjuvant therapy should be considered for patients with large tum
ors and invasive disease.